Cargando…
Clinical value of glucocorticoids for severe community-acquired pneumonia: A systematic review and meta-analysis based on randomized controlled trials
BACKGROUND: Severe community-acquired pneumonia (sCAP) is characterized by severe symptoms and a poor prognosis, especially with the recent global impact of novel coronavirus in recent years. The use of glucocorticoids in sCAP is currently a subject of debate. To evaluate the clinical efficacy and s...
Autores principales: | Peng, Biao, Li, Jin, Chen, Minwei, Yang, Xianghui, Hao, Meng, Wu, Feifei, Yang, ZhiChao, Liu, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659673/ https://www.ncbi.nlm.nih.gov/pubmed/37986401 http://dx.doi.org/10.1097/MD.0000000000036047 |
Ejemplares similares
-
The prognostic value of geriatric nutritional risk index in elderly patients with severe community-acquired pneumonia: A retrospective study
por: Wei, Lishuang, et al.
Publicado: (2020) -
Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality
por: Li, Hai-yan, et al.
Publicado: (2015) -
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia
por: Lai, Chih-Cheng, et al.
Publicado: (2023) -
Serum levels of SIRT3 and other inflammatory factors are associated with clinical outcomes and prognosis in severe community-acquired pneumonia in adults: A prospective study
por: Zhu, Wei, et al.
Publicado: (2021) -
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: A case report
por: Xia, Huan, et al.
Publicado: (2020)